Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab Retreatment Extension in Lupus Nephritis
NCT00404157Phase 3Withdrawn
- Sponsor
- Genentech
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in lupus nephritis (LN), sponsored by Genentech. Status: withdrawn.
02
Drugs
rituximab
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT00404157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404157.